ICICI Prudential Asset Management Company Ltd.
Banking · NSE
52-week range
₹2,517 – ₹3,598
From 52w high
-10.1%
RSI (14)
50.7
vs SMA 50 / 200
↑ 50 · ↓ 200
ICICI Prudential AMC (ICICIAMC) operates in asset management and reported Q4 FY26 net profit growth of approximately 58% year-on-year. The stock trades at ₹3,233 with a trailing PE of 48.6x (forward PE 34.7x), ROE of 85.8%, and a 54.96% profit margin — metrics that rank it first among its reported peer group on profitability. With only 94 days of price history available, longer-term technical context is limited.
- ✓ROE of 85.8% and profit margin of 54.96% are the highest in the reported peer group (next-best ROE: Bajaj Finance at 17.91%), indicating a capital-light, high-conversion business model typical of mature asset managers.
- ✓FCF was positive in 4 of the available years and ROE stayed above 15% in 4 of available years; persistence consistency score is 88, reflecting durable earnings quality across the data window.
- ✓8 news items over the period — 6 positive, 2 neutral, 0 negative — include a Q4 earnings release cited for 58% net profit growth and AUM expansion, with no negative news flow detected.
- ✓Forward PE of 34.7x represents a ~29% compression from the trailing PE of 48.6x if FY27 earnings estimates are met, implying the market is pricing in material earnings step-up.
- ✗Sector peer classification under Banking produces a distorted comparison set; ICICIAMC PE of 48.6x is the highest among 6 peers whose median trailing PE is approximately 24x, reflecting either a sector-premium for the AMC model or a valuation gap that narrows only if earnings growth accelerates beyond the 5-year CAGR of 10.4%.
- ✗Revenue 5-year CAGR of 8.2% is modest relative to the trailing multiple of 48.6x; sustaining this valuation requires earnings outperformance relative to historical topline growth.
- ✗SMA-200 is computationally unavailable (only 94 price bars); 1-year price return is also null — the stock lacks sufficient listing history for standard trend-following and return analysis, reducing the reliability of technical signals.
- ✗A SEBI settlement was reached in April 2026 regarding a legacy real estate venture fund; while resolved, the existence of a regulatory compliance event in the public record is a qualitative factor for review.
- ·Q4 FY26 results (reported mid-April 2026) showed 58% net profit growth year-on-year; TradingView analysis cited strong revenue, profit, and AUM growth with high ROE maintained, with Centrum flagging it as a top pick after the results.
- ·ICICI Prudential AMC secured a SEBI settlement (April 20, 2026) on a legacy real estate venture fund matter — the settlement closes the regulatory loop but introduces a compliance event to the public record.
- ·Prabhudas Lilladher cited a price target of ₹3,585 for the stock (Moneycontrol, April 15, 2026), representing approximately 10.9% above the current price of ₹3,233; this is a third-party broker view, not a VivaTrades assessment.
- ?Does the 85.8% ROE reflect a structural advantage in the AMC business model, or is it partly a function of current equity market conditions that could compress if AUM flows slow?
- ?Given that revenue has grown at 8.2% over 5 years while the trailing PE stands at 48.6x, what earnings growth rate would need to materialize over the next 3–5 years to justify the current multiple?
- ?How does the SEBI settlement on the legacy real estate venture fund affect the companys compliance track record, and are there other legacy matters that could surface?
- ?With only 94 trading days of price history, what additional time or data milestones would allow a more complete technical and return-based assessment of this stock?
PE
48.6
Forward PE
34.7
ROE
+85.8%
Profit margin
+55.0%
D/E
—
Dividend yield
+0.9%
Quality score
55/100
ROE 5y above 15%
4/5 yrs
FCF 5y positive
4/5 yrs
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.Analysis generated 11 May 2026.

